| RS151340626 |
CLCN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatemic rickets, X-linked recessive |
| RS151340627 |
CLCN5
|
Health Risk |
Pathogenic |
Proteinuria, low molecular weight |
| RS151340628 |
CLCN5
|
Health Risk |
Pathogenic |
Proteinuria, low molecular weight |
| RS151340629 |
CLCN5
|
Health Risk |
Pathogenic |
X-linked recessive nephrolithiasis with renal failure, X-linked recessive nephrolithiasis with renal failure |
| RS151340630 |
CLCN5
|
Health Risk |
Pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS151340631 |
ATP7A
|
Health Risk |
Pathogenic |
Cutis laxa, X-linked |
| RS151340632 |
ATP7A
|
Health Risk |
Pathogenic |
Cutis laxa, X-linked |
| RS151340633 |
ATP7A
|
Health Risk |
Pathogenic |
Menkes kinky-hair syndrome, X-linked distal spinal muscular atrophy type 3 |
| RS151341424 |
STRA6
|
Health Risk |
Pathogenic |
Microphthalmia, isolated |
| RS151344454 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344455 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344462 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344466 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344467 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344470 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344473 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344474 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS151344481 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344482 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS151344484 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344487 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344491 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS151344492 |
CYBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS151344496 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS151344497 |
CYBB
|
Health Risk |
Pathogenic |
X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency, Chronic granulomatous disease |
| RS151344498 |
CYBB
|
Health Risk |
Pathogenic |
X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency, Chronic granulomatous disease |
| RS151344503 |
CYP21A2
|
Health Risk |
Pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS151344504 |
CYP21A2
|
Health Risk |
Pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS151344505 |
CYP21A2
|
Health Risk |
Conflicting classifications of pathogenicity |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS151344506 |
CYP21A2
|
Health Risk |
Pathogenic |
Hyperandrogenism, nonclassic type |
| RS151344512 |
AFG3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 28, AFG3L2-related disorder |
| RS151344513 |
AFG3L2
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS151344514 |
AFG3L2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 28, Optic atrophy 12 |
| RS151344515 |
AFG3L2
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS151344517 |
AFG3L2
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS151344518 |
AFG3L2
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS151344519 |
AFG3L2
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS151344520 |
AFG3L2
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS151344521 |
AFG3L2
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS151344522 |
AFG3L2
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS151344523 |
AFG3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS151344525 |
TFAP2A
|
Health Risk |
Pathogenic |
Branchiooculofacial syndrome, Inborn genetic diseases |
| RS151344526 |
TFAP2A
|
Health Risk |
Likely pathogenic |
Branchiooculofacial syndrome, Branchiooculofacial syndrome |
| RS151344527 |
TFAP2A
|
Health Risk |
Likely pathogenic |
Branchiooculofacial syndrome, Branchiooculofacial syndrome |
| RS151344528 |
TFAP2A
|
Health Risk |
Pathogenic |
Branchiooculofacial syndrome, Inborn genetic diseases |
| RS151344530 |
TFAP2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Branchiooculofacial syndrome |
| RS151344531 |
TFAP2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Branchiooculofacial syndrome, Inborn genetic diseases |
| RS151344623 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS151344624 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS151344629 |
NLRP3
|
Health Risk |
Pathogenic |
Familial cold autoinflammatory syndrome 1, Familial amyloid nephropathy with urticaria AND deafness |
| RS151344630 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS151344631 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome 1, Congenital long QT syndrome |
| RS1532268 |
MTRR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS1537044 |
NECTIN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia-syndactyly syndrome 1, NECTIN4-related disorder |
| RS154774633 |
CLN6
|
Health Risk |
Pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS154774634 |
CLN6
|
Health Risk |
Pathogenic/Likely pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS154774635 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Ceroid lipofuscinosis, neuronal |
| RS154774636 |
CLN6
|
Health Risk |
Pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS154774639 |
CLN6
|
Health Risk |
Pathogenic/Likely pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS154774640 |
CLN6
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS1551570 |
PPAN
|
Health Risk |
association |
Cataplexy and narcolepsy, Cataplexy and narcolepsy |
| RS1553120047 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1553120055 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1553120110 |
SELENON
|
Health Risk |
Pathogenic/Likely pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1553120202 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1553120678 |
SELENON
|
Health Risk |
Pathogenic |
— |
| RS1553120691 |
SELENON
|
Health Risk |
Pathogenic/Likely pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1553121072 |
DHDDS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 59, Retinitis pigmentosa 59 |
| RS1553121073 |
DHDDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay and seizures with or without movement abnormalities, Retinitis pigmentosa 59 |
| RS1553121290 |
PGM1
|
Health Risk |
Conflicting classifications of pathogenicity |
PGM1-congenital disorder of glycosylation, PGM1-congenital disorder of glycosylation |
| RS1553121545 |
DHDDS
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type Ibb |
| RS1553121678 |
RPL11
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 7, Diamond-Blackfan anemia 7 |
| RS1553121684 |
RPL11
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1553121689 |
RPL11
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 7, Diamond-Blackfan anemia 7 |
| RS1553121795 |
RPL11
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1553121852 |
RPL11
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 7 |
| RS1553121887 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1553121909 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1553122256 |
YARS1
|
Health Risk |
Pathogenic |
Neurologic, endocrine |
| RS1553122784 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1553122785 |
YARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate C, Inborn genetic diseases |
| RS1553122794 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1553122801 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1553122804 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1553122883 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1553122918 |
PARK7
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis-parkinsonism-dementia complex, Amyotrophic lateral sclerosis-parkinsonism-dementia complex |
| RS1553122926 |
DHDDS
|
Health Risk |
Pathogenic |
Developmental delay and seizures with or without movement abnormalities, Retinitis pigmentosa 59 |
| RS1553122929 |
PARK7
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 7, Autosomal recessive early-onset Parkinson disease 7 |
| RS1553122949 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1553122996 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1553123017 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1553123034 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1553123054 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1553123071 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1553123105 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1553123252 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1553123263 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1553123702 |
YARS1
|
Health Risk |
Pathogenic |
Neurologic, endocrine |
| RS1553123857 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1553123858 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |